News | March 06, 2026
CordenPharma expands boulder presence with 64,000-Sq-Ft Lease at BioMed Realty’s Flatiron Park
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
The Silver Medal recognizes strong performance across sustainability, ethics, environment, labour & human rights, and responsible procurement
Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality
The collaboration will leverage Medi Assist’s proprietary technology to streamline claims processing, enhance transparency, and deliver smarter health benefits to policyholders in the region
Asahi Kasei Pharma receives worldwide exclusive rights for the research, development, manufacturing, and marketing of the active ingredients
The new patents cover critical advancements in cochlear implant technology
Brivaracetam Oral Solution (10 mg/mL) is a prescription antiepileptic drug (anticonvulsant) used for treatment of partial-onset seizures in patients 1 month of age and older
The alliance directly links VivaMed’s computational drug hypotheses with Syngene’s preclinical development capabilities
The project entails a total planned capital expenditure of approximately Rs. 500 - 520 crore
TED?A9 is part of S.Biomedics’ expanding pipeline of stem-cell-based therapies, developed using the company’s proprietary targeted embryonic stem cell differentiation platform
Subscribe To Our Newsletter & Stay Updated
